Upadacitinib: An Evolving Treatment for Ulcerative Colitis
The inhibition of Janus kinase to prevent downstream signaling of proinflammatory cytokines has been shown to be a novel method of treating ulcerative colitis.
Risankizumab: A New Treatment Option for Crohn’s Disease
Risankizumab represents the first ever IL-23 treatment for adult patients with Crohn's disease approved by the FDA.
Introducing The Qazi Corner: A Gastroenterology Newsletter Featuring Taha Qazi, MD
The Qazi Corner will be a quarterly newsletter led by Taha Qazi, MD, of the Cleveland Clinic and featuring new data, conference highlights, and perspectives of leading gastroenterologists.
2 Clarke Drive Cranbury, NJ 08512